RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Moura, Filipe [1 ]
Berg, David [1 ]
Bellavia, Andrea [1 ]
Mosenzon, Ofri [1 ]
Dwyer, Jamie [1 ]
Scirica, Benjamin M. [1 ]
Wiviott, Stephen [1 ]
Bhatt, Deepak L. [1 ]
Raz, Itamar [1 ]
Feinberg, Mark William [1 ]
Morrow, David A. [1 ]
Sabatine, Marc Steven [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1493-176
引用
收藏
页码：1808 / 1808
页数：1
相关论文
共 50 条
  • [31] The effect of SGLT2 inhibitors on drugnaive obese type 2 diabetes mellitus patients
    Chikazawa, Shinji
    Matsuhashi, Yuki
    Tando, Yusuke
    Daimon, Makoto
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S103 - S103
  • [32] Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus
    Ribola, F. A.
    Cancado, F. B.
    Schoueri, J. H. M.
    De Toni, V. F.
    Medeiros, V. H. R.
    Feder, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) : 199 - 211
  • [33] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
    Mahling, Moritz
    Schork, Anja
    Nadalin, Silvio
    Fritsche, Andreas
    Heyne, Nils
    Guthoff, Martina
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 984 - 992
  • [34] Remogliflozin (SGLT2 Inhibitor) Significantly Reduces Albuminuria and Delays the Progression of Nephropathy in Type 2 Diabetes Mellitus Patients
    Gupta, Vishal K.
    DIABETES, 2020, 69
  • [35] Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
    Singh, Mahakpreet
    Sharma, Ruchika
    Kumar, Anoop
    CURRENT DRUG SAFETY, 2019, 14 (02) : 87 - 93
  • [36] Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
    Solini, Anna
    ACTA DIABETOLOGICA, 2016, 53 (06) : 863 - 870
  • [37] Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
    Anna Solini
    Acta Diabetologica, 2016, 53 : 863 - 870
  • [38] Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
    Kaushal, Shaveta
    Singh, Harmanjit
    Thangaraju, Pugazhenthan
    Singh, Jasbir
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (03) : 107 - 113
  • [39] SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes.
    Guthoff, M.
    Mahling, M.
    Nadalin, S.
    Heyne, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 554 - 554
  • [40] Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus
    Tsapas, A.
    Vassilakou, D.
    Athanasiadou, E.
    Karagiannis, T.
    Matthews, D. R.
    DIABETOLOGIA, 2012, 55 : S107 - S107
12345